Abstract
Pseudomyxoma peritonei (PMP) is a rare condition complicated by intra-abdominal spread that can cause multilevel gastrointestinal (GI) obstruction. Parenteral nutrition (PN) use in the context of palliative care and malignancy remains controversial. We describe the use of palliative PN in three patients with progressive PMP causing multilevel GI obstruction and intestinal failure. All patients received >90 days of PN. PN was safe in this cohort of patients. However, patient selection and the timing of intervention are important factors when considering the initiation of PN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA . Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008; 34: 196–201.
Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M ESPEN. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 2009; 28: 445–454.
Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D . Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution’s 20-year experience. Cancer 2005; 103: 863–868.
Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 2014; 25: 487–493.
Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 2004; 20: 760–763.
Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol 2011; 28: 83–88.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Disney, B., Karthikeyakurup, A., Ratcliffe, J. et al. Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series. Eur J Clin Nutr 69, 966–968 (2015). https://doi.org/10.1038/ejcn.2015.97
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.97
This article is cited by
-
Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract origin
European Journal of Clinical Nutrition (2021)